Update news glaxosmithkline

Multinationals riding high in Vietnam’s pharma landscape

Multinational corporations like Sanofi, GlaxoSmithKline, and Reckitt Benckiser gaining the advantage in Vietnam’s over-the-counter channel, or non-description drugs, in the first quarter of 2020 has in part fuelled their global performance.

Drug price hikes in US threaten the same in Vietnam?

Pfizer, Sanofi, and GlaxoSmithKline are reported to plan increasing drug prices in the US in 2020, triggering public concerns over a similar hike in Vietnam.